Boucher, Helen W <br/><br/>
Is it possible to blind a trial for community-acquired pneumonia?  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Dec 2008 
 - S210-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1086/591428  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--adverse effects<br/>Community-Acquired Infections--drug therapy<br/>Double-Blind Method<br/>Drug-Related Side Effects and Adverse Reactions<br/>Humans<br/>Pneumonia, Bacterial--drug therapy<br/>Randomized Controlled Trials as Topic--methods<br/>Treatment Outcome